AB Sciex, Genedata, and LECO Announce Technology Partnership
AB Sciex (Basel, Switzerland), Genedata (Basel, Switzerland), and LECO (Michigan, USA) have announced a technology partnership. The partnership will aim to deliver a collaborative software system for metabolomics researchers. The companies will work together to formulate a solution for the extraction of data from high fidelity liquid chromatography (LC) and gas chromatography (GC) data.
AB Sciex (Basel, Switzerland), Genedata (Basel, Switzerland), and LECO (Michigan, USA) have announced a technology partnership. The partnership will aim to deliver a collaborative software system for metabolomics researchers. The companies will work together to formulate a solution for the extraction of data from high fidelity liquid chromatography (LC) and gas chromatography (GC) data.
“The ability to bring data from different vendors and technologies onto a single platform, which can process and merge data for maximum biological inference, is where the industry needs to be to effectively evaluate the entire metabolome,” said Dr Vladimir V. Tolstikov, from Tailored Therapeutics of Eli Lilly and Company.
For more information please visit:
www.absciex.com
www.genedata.com
www.leco.com
Detailed Glycosylation Analysis of Therapeutic Enzymes Utilizing Comprehensive 2D-LC–MS
January 3rd 2025In this article, the use of comprehensive two-dimensional liquid chromatography (LC×LC) coupled to mass spectrometry (MS) for characterizing glycosylation of therapeutic enzymes is presented.
Advancing Gene Therapy: Enzyme Selection for Effective RNA Oligonucleotide Mapping
New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), continue to make progress in both primate and first-in-human trials. As this progress builds, the industry remains accountable for characterizing these molecules to meet the requirements of regulatory authorities.
